Pharma Journalist -

LifeMine Therapeutics Inc., a biopharmaceutical company reinventing drug discovery by mining genetically-encoded small molecules (GEMs) from the biosphere, announced a strategic R&D…
Read More...

Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India Pvt. Ltd. (SII),…
Read More...

Affini-T Therapeutics, Inc., a biotechnology company unlocking the power of T cells against oncogenic driver mutations, announced the completion of an oversubscribed $175 million…
Read More...

Acasti Pharma Inc. announces the following patent notifications and awards relating to the Company’s three lead drug candidates: The European Patent Office has provided notice of…
Read More...

Pfizer Inc. announced an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir tablets and ritonavir tablets), to 95…
Read More...

Proscia, a leader in digital and computational pathology solutions, and Visiopharm, a world leader in AI-driven precision pathology software, today announced a strategic partnership to…
Read More...

Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel combination therapy,…
Read More...

Assessing device development and regulation for advanced innovation SMi’s 6th Annual Conference Pre-Filled Syringes West Coast June 13 - 14, 2022 | San Diego, CA, USA…
Read More...

SMi Group reports: 6th Annual Highly Potent API Conference will return in May 2022 SMi Group has been working the Highly Potent Active Pharmaceutical Ingredients industry for 6 years…
Read More...

Merck announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, as a single agent for the treatment of patients with advanced…
Read More...